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In Brief
IKKb is known to be a proinflammatory
mediator. However, IKKb in adipocytes
also mediates IL-13 expression to sup-
press high-fat-diet-induced inflammation
in adipose tissue. This feedback mecha-
nism may be the molecular basis of diet-
induced chronic low-grade inflammation,
resulting in systemic insulin resistance.
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Adipose tissue inflammation is one pathway shown
to mediate insulin resistance in obese humans and
rodents. Obesity induces dynamic cellular changes
in adipose tissue to increase proinflammatory cyto-
kines and diminish anti-inflammatory cytokines.
However, we have found that anti-inflammatory
interleukin-13 (IL-13) is unexpectedly induced in adi-
pose tissue of obese humans and high-fat diet (HFD)-
fed mice, and the source of IL-13 is primarily the
adipocyte. Moreover, HFD-induced proinflammatory
cytokines such as tumor necrosis factor alpha (TNF-
a) and IL-1b mediate IL-13 production in adipocytes
in an IKKb-dependent manner. In contrast, adipo-
cyte-specific IKKb-deficient mice show diminished
IL-13 expression and enhanced inflammation after
HFD feeding, resulting in a worsening of the insulin-
resistant state. Together these data demonstrate
that although IKKb activates the expression of proin-
flammatory mediators, in adipocytes, IKKb signaling
also induces the expression of the anti-inflammatory
cytokine IL-13, which plays a unique protective role
by limiting adipose tissue inflammation and insulin
resistance.INTRODUCTION
Inflammation is an important process for the development of
insulin resistance in obese humans and rodents, and adipose
tissue is a major site mediating the inflammatory response (Ho-
tamisligil, 2006; Kwon and Pessin, 2013; Schenk et al., 2008;
Shoelson et al., 2006). Adipose tissue consists of a variety of
cell types, and recent studies have established that a high-fat
diet (HFD) results in inflammation with dynamic cellular changes
in adipose tissue (Feuerer et al., 2009; Liu et al., 2009; Lynch
et al., 2012; Molofsky et al., 2013; Nishimura et al., 2009, 2013;
Schipper et al., 2012; Talukdar et al., 2012; Winer et al., 2009,1574 Cell Reports 9, 1574–1583, December 11, 2014 ª2014 The Aut2011; Wu et al., 2011). The proinflammatory Th1 cytokines
such as Interferon-g are increased in obese humans and rodents
to induce the differentiation of classically activated macro-
phages (M1) and Th1 CD4+ T cells, whereas the anti-inflamma-
tory Th2 cytokines including IL-4, which mediate differentiation
of alternatively activated macrophages (M2) and Th2 CD4+
T cells, are decreased (Lumeng et al., 2007; Martinez et al.,
2009; Molofsky et al., 2013; Winer et al., 2009; Wu et al., 2011).
IL-10 also suppresses the inflammation in adipose tissue, and
its expression was decreased due to depletion of Foxp3+CD4+
regulatory T cells (Treg) and regulatory B cells in obesity (Feuerer
et al., 2009; Nishimura et al., 2013). Th2 CD4+ T cells and innate
lymphoid type 2 cells (ILC2s) express another Th2 cytokine Inter-
leukin-13 (IL-13) to sustain anti-inflammatory M2 macrophages
and eosinophils (Molofsky et al., 2013; Winer et al., 2009). How-
ever, Th2 CD4+ T cells and ILC2 cells are decreased in obese
mice as part of the adipose tissue proinflammatory activation
pathway.
Proinflammatory mediators such as tumor necrosis factor
alpha (TNF-a), IL-1b, saturated free fatty acids (FFAs), and endo-
toxins stimulate nuclear factor-kB (NF-kB) activation through the
IKK complex in obesity (Oeckinghaus et al., 2011). IKKb is an es-
tablished critical signaling molecule to modulate HFD-induced
inflammation and insulin resistance and as a target for an anti-in-
flammatory therapy (Baker et al., 2011; Tornatore et al., 2012;
Yuan et al., 2001). Expression of constitutively active IKKb in
hepatocytes enhances inflammation in liver, resulting in glucose
intolerance and insulin resistance (Cai et al., 2005). Accordingly,
hepatocyte-specific IKKb-deficient mice show suppressed
HFD-induced inflammation and liver insulin resistance (Arkan
et al., 2005). Deletion of IKKb in macrophages shows systemic
suppression of HFD-induced inflammation, resulting in improved
glucose tolerance and insulin sensitivity (Arkan et al., 2005). IKKb
also mediates inflammation in hypothalamus and heart. Deletion
of IKKb in hypothalamus suppresses HFD-induced inflammation
and insulin resistance (Zhang et al., 2008). In addition, constitu-
tively active IKKb expression in cardiomyocytes enhances
inflammation and cardiomyopathy (Maier et al., 2012). Thus,
these data suggest that IKKb in diverse cells behaves as a proin-
flammatory modulator to mediate HFD-induced inflammation
and insulin resistance. However, the role of IKKb in adipocyteshors
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Figure 1. HFD Enhanced the Expression of
IL-13 in Adipocytes
(A) Expression of inflammatory mediators in
epididymal adipose tissues of HFD-fed C57BL/6J
mice (n = 7–8 per group).
(B and C) IL-4 and IL-13 expression in epididymal
adipose tissues of normal chow (NC) and high-fat
(HF) diet-fed C57BL/6J mice (n = 7–8 per group).
(D) IL-13 level in plasma of HFD-fed C57BL/6J
mice (n = 8–10 per group).
(E) Expression of inflammatory cytokines in
omental adipose tissues of lean and obese
humans.
(F) IL-13 expression in omental adipose tissue of
lean and obese humans (lean: BMI = 24.9 ± 1.3,
n = 5; obese: BMI = 45.4 ± 2.1, n = 11).
(G and H) IL-13 and IL-4 expression in SVF and
ACF of NCD- and HFD-fed mice (n = 4–6 per
group).
All data are the mean ± SEM, *p < 0.005 compared
with NC, **p < 0.035 compared with lean.has not been studied. We demonstrate here that the IKKb
signaling pathway in adipocytes, in contrast to most other tis-
sues (Arkan et al., 2005; Cai et al., 2005; Maier et al., 2012;
Yuan et al., 2001; Zhang et al., 2008), plays an anti-inflammatory
modulatory role through an IKKb-IL-13 axis to limit HFD-induced
adipose tissue inflammation and insulin resistance.
RESULTS
HFD Induced the Expression of IL-13 in Adipocytes
IL-4 and IL-13 are critical for the differentiation of anti-inflamma-
tory immune subsets, M2macrophages, and Th2 CD4+ T cells toCell Reports 9, 1574–1583, Desuppress inflammation (Guo et al.,
2012; Van Dyken and Locksley, 2013).
Cytokine/chemokine profiling of mouse
epididymal adipose tissue from normal
chow diet (NCD) and HFD-fed mice
demonstrated the expected increase in
proinflammatory gene expression such
as TNF-a, IL-6, CCL2, CCL5, and CCR5
and the enhanced infiltration of macro-
phages indicated by increased Emr1 (Fig-
ure 1A). In addition, the expression of
anti-inflammatory Th2 cytokine IL-4 was
diminished in epididymal adipose tissues
of HFD-fed mice (Figure 1B). However,
the expression of another typical anti-in-
flammatory Th2 cytokine IL-13was signif-
icantly increased in adipose tissue of the
HFD-fed mice (Figure 1C). In parallel, IL-
13 protein levels were also increased in
plasma of the HFD-fed mice (Figure 1D).
To determine whether IL-13 expression
was also enhanced in obese humans,
omental adipose tissue was isolated
from patients undergoing bariatric sur-gery. Similar to HFD-fed mice, obese humans demonstrated
the increased expression of proinflammatorymarkers (Figure 1E)
in omental adipose tissues. Omental adipose tissues prepared
from obese humans also showed marked increase in IL-13
gene expression (Figure 1F). These results suggest that anti-
inflammatory IL-13 expression in adipose tissue is increased in
both obese mice and humans.
Th2 CD4+ T cells, eosinophils, NKT cells, and ILC2 cells have
been shown as major sources of IL-4 and IL-13. However, Th2
CD4+ T cells, eosinophils, NKT cells, and ILC2 cells are
decreased in adipose tissue of HFD-fed mice (Feuerer et al.,
2009; Lynch et al., 2012; Molofsky et al., 2013; Nishimuracember 11, 2014 ª2014 The Authors 1575
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Figure 2. IL-1b and TNF-a Induced the Expression of IL-13 in Adi-
pocytes, and HFD-Induced IL-13 Expression in Adipocytes Was
Diminished in Adipocyte-Specific IKKb Knockout Mice
(A) TNF-a and IL-1b-induced IL-13 expression in 3T3-L1 adipocytes. Cyto-
kines (20 ng/ml except IL-1b [10 ng/ml]) were treated for 1 or 6 hr (n = 4–6 per
group).
(B and C) FFA and endotoxin did not induce IL-13 expression in 3T3-L1
adipocytes (n = 4). FFA (1 mM palmitate and BSA adduct) and endotoxin LPS
(50 ng/ml) were treated for 6 hr.
1576 Cell Reports 9, 1574–1583, December 11, 2014 ª2014 The Autet al., 2009; Winer et al., 2009; Wu et al., 2011), suggesting that a
different cell population is responsible for IL-13 expression in
adipose tissue of HFD-fed mice. Thus, we isolated adipocyte
fraction (ACF) and stromal vascular fraction (SVF) and then
compared the expression of IL-13. IL-13 expression in SVF
was comparable in both NCD and HFD fed mice (Figure 1G).
In contrast, IL-13 expression was significantly increased in the
ACF of HFD-fed mice (Figure 1G). However IL-4 expression
was decreased in the SVF of the HFD-fedmice andwas relatively
low and unchanged in the ACF (Figure 1H). These data are
consistent with previous studies demonstrating that the two
cell populations Th2 CD4+ T cells and eosinophils that secrete
IL-4 are decreased in adipose tissue of HFD-fed mice (Winer
et al., 2009; Wu et al., 2011), but in contrast indicate that HFD in-
duces the expression of anti-inflammatory IL-13 in adipocytes.
IL-1b and TNF-a Synergistically Induced the Expression
of IL-13 in Adipocytes
Previously it has been suggested that adipocytes have the
capacity to express IL-13, and adipocytes culture conditioned
media containing IL-13 induces M2 macrophage differentiation
(Kang et al., 2008). We therefore examined the expression of
IL-13 in 3T3-L1 adipocytes treated with diverse cytokines, which
are expressed in adipose tissues (Figure 2A). TNF-a induced IL-
13 expression in a transient manner following 1 hr of TNF-a treat-
ment but not following 6 hr. In contrast, IL-1b induced IL-13
expression in a more persistent manner, being increased at
both 1 and 6 hr (Figure 2A), suggesting that IL-1b was able to
induce persistent IL-13 expression in 3T3-L1 adipocytes. In
addition to increased inflammatory cytokines, hyperlipidemia
and endotoxemia also cause inflammation in adipose tissues.
Thus, we examined the expression of IL-13 with saturated FFA
and endotoxin treatment in 3T3-L1 adipocytes. Similarly, IL-1b,
LPS, and palmitate induced IL-6 expression (Figure 2C), but
again, only IL-1b induced IL-13 expression in 3T3-L1 adipocytes
(Figure 2B). As TNF-a transiently induced IL-13 expression,
whereas IL-1b had a more persistent effect, we examined the
potential synergy between TNF-a and IL-1b. The combination
of TNF-a and IL-1b stimulation resulted in nearly an approximate
10-fold induction of IL-13 expression (Figure 2D). In parallel,
there was a concomitant increase in IL-13 protein secretion (Fig-
ure 2E). These results indicate that IL-1b is a major driver of IL-13
expression and that TNF-a synergizes with IL-1b to further
enhance IL-13 expression in adipocytes.(D and E) TNF-a and IL-1b-induced synergistic expression of IL-13 in 3T3-L1
adipocytes (n = 4–8 per group). Cytokines were treated for 6 hr. All data are the
mean ± SEM, *p < 0.0007 compared with control (Ctrl), **p < 0.0003 compared
with IL-1b.
(F) IKKb expression in WT and Ad-IKKbKO (KO) mice. NCD-fed mice
(5–7 weeks old) were used.
(G) Food intake and energy expenditure (EE) of WT and Ad-IKKbKO (KO) mice
after NCD or HFD feeding for 12–14 weeks (n = 4–6 per group).
(H) IL-13 expression in epididymal adipose tissues of HFD-fed WT (WT-HF)
and Ad-IKKbKO (KO-HF) mice (n = 5–7 per group).
(I) IL-13 expression in ACF prepared from HFD-fed WT and Ad-IKKbKO (n =
5–7 per group).
All data are the mean ± SEM, *p < 0.004 compared with NC, **p < 0.0034
compared with WT-HF, ***p < 0.0001 compared with WT ACF-HF.
hors
Adipocyte-Specific IKKb Deletion Abrogated HFD-
Induced IL-13 Production
Since IL-1b as well as TNF-a activates NF-kB signaling pathway
through IKKb activation, we generated adipocyte specific IKKb--
deficient (Ad-IKKbKO) mice by crossing the Ikbkb floxed mice
with adiponectin-Cre mice. As expected, there was an approxi-
mate 50% reduction in IKKb protein in white adipose tissue with
a greater decrease in IKKb protein in brown adipose tissue (Fig-
ure 2F). We also examined IKKb protein levels in the SVF and ad-
ipocytes in white adipose tissue. As readily apparent, there was
no reduction in IKKb protein in the SVF but a near complete loss
of IKKb in adipocytes. The specificity of the IKKb knockout was
further confirmed because there was no change in IKKb protein
levels in bone marrow-derived macrophages (Bm-MPs) (Fig-
ure 2F) and in IKKbmRNA levels inmuscle, pancreas, liver, brain,
and splenocytes (Figure S1A), suggesting that IKKb expression
is specifically deleted in adipocytes.
Having demonstrated the adipocyte specific deletion of IKKb,
we characterized the metabolic and inflammatory phenotype of
these mice. The WT and Ad-IKKbKO mice had similar body
weights on a NCD. Similarly, the age-dependent increase body
weight and relative proportions between fat mass and lean
mass were not significantly different after NCD and HFD feeding
ofWT andAd-IKKbKOmice (Figure S1B).Moreover, the extent of
HFD-induced increase in white adipose tissue mass (epididymal
and subcutaneous) was similar between theWT and Ad-IKKbKO
mice (Figure S1C).We then examined the food intake and energy
expenditure using Oxymax indirect calorimetry system. As we
expected, there were no significant differences in food intake
andenergy expenditure inNCDandHFD-fedWTandAd-IKKbKO
mice (Figure 2G). Thesemice also showed similar respiratory ex-
change rate and spontaneous locomotor activity (Figure S1D).
As we found that adipocyte-specific IKKb deletion did not
affect body weight, fat accumulation, and energy expenditure,
we next determined the effect of IKKb on the IL-13 expression
in epididymal adipose tissues of WT and Ad-IKKbKO mice. As
previously observed, IL-13 expression inWTmicewas increased
in epididymal adipose tissue following HFD feeding. However,
the HFD-induced IL-13 expression was significantly blunted in
the Ad-IKKbKOmice (Figure 2H). Furthermore, in isolated adipo-
cytes, the loss of IKKb completely suppressed the HFD-induced
induction of IL-13 expression (Figure 2I). As the isolated ACFwas
highly enriched for the adipocyte-specific marker (Lep) and de-
enriched for the T cell (Cd3g) and macrophage (Itgma) markers
(Figure S2A), these results confirm that IKKb is critical for HFD-
induced IL-13 expression in adipocytes.
Adipocyte-Specific IKKb Deletion Enhanced
Inflammatory Cytokine Production in Adipose Tissue
As adipocyte-specific IKKb deletion reduced the HFD-induced
IL-13 expression in adipocytes, we determined the effects of
suppressed IL-13 expression on adipose tissue inflammation.
The gene expression of typical proinflammatory cytokines was
increased in HFD-fed WT mice (Figure 3A). Interestingly, the
reduction in adipocyte-specific IKKb signaling and IL-13 expres-
sion resulted in enhanced epididymal adipose tissue proinflam-
matory gene expression after HFD feeding with no significant
change in NCD-fed mice. The increase in proinflammatoryCell Regene expression also directly correlated with increased secre-
tion of the corresponding inflammatory cytokine proteins (Fig-
ure S2B). These data suggest that diminished HFD-induced
IL-13 expression promotes the epididymal adipose tissue
inflammation in Ad-IKKbKO mice.
In contrast to epididymal adipose tissue, subcutaneous adi-
pose tissue of WT mice did not display any significant increase
in inflammatory cytokine expression under these conditions of
HFD feeding. Moreover, there was no increased inflammatory
cytokine marker expression in subcutaneous adipose tissue
in the HFD-fed Ad-IKKb KO mice. These data indicate that
although epidiymal adipose tissue is sensitive to HFD-induced
inflammation, subcutaneous adipose tissue is relatively resistant
even in Ad-IKKbKO mice (Figure 3A). To confirm the enhanced
immune cell infiltration in adipose tissues of HFD-fed Ad-IKKbKO
mice, we stained epididymal adipose tissues with hematoxylin-
eosin (H&E) (Figure 3B). NCD-fed WT and Ad-IKKbKO mice
showed comparable adipocytes size and morphology with little
infiltration and crown-like structure. In contrast, HFD-fed WT
and Ad-IKKbKO mice showed enlarged adipocytes with HFD-
induced crown-like structure, and Ad-IKKbKO mice have more
severe cell infiltration and crown-like structure (Figure 3B).
Consistent with inflammatory gene expression (Figure 3A), H&E
staining of subcutaneous adipose tissue fromWT or Ad-IKKbKO
mice displayed little infiltration in either NCD or HFD-fed mice
despite the marked increase in adipocyte cell size following
HFD feeding (Figure 3C). To examine the consequences of
inflammation in Ad-IKKbKOmice, we conducted glucose and in-
sulin tolerance test. The greater proinflammatory gene expres-
sion of the HFD-fed Ad-IKKbKO compared with HFD-fed WT
mice was also reflected by a further impairment of glucose toler-
ance and insulin sensitivity (Figures 3D and 3E).
The liver is relatively resistant to HFD-induced inflammation
requiring longer periods of HFD feeding with a lesser extent of in-
flammatory gene marker expression compared to epididymal
adipose tissue (Fontana et al., 2013). Although HFD had little
effect on liver inflammation of the WT mice, there was a clear
induction of liver proinflammatory markers in the HFD-fed Ad-
IKKbKO mice (Figure 3F). The increase in tissue inflammation,
along with the impairment of glucose tolerance and insulin sensi-
tivity, was molecularly linked to reduction in insulin signaling
assessed by a reduction in insulin-stimulated AKT-Thr308 and
AKT-Ser473 phosphorylation (Figure 3G).
Adipocyte-Specific IKKb Deletion Increased Infiltration
of Proinflammatory Immune Cells in Adipose Tissue
To identify the cell populations responsible for the increased
inflammation in HFD-fed Ad-IKKbKO mice, we examine the
macrophage profiles of adipose tissue using flow cytometry
(Figure S3A). The Ad-IKKbKO mice displayed increased F4/
80+CD11c+ macrophages and F4/80+CD11c+CD206+ macro-
phages compared with adipose tissue of WT mice on a HFD
(Figures 4A and 4B). Using a generic definition of F4/
80+CD11cCD206+ as M2, F4/80+CD11c+CD206 as M1 and
F4/80+CD11c+CD206+ as mixed M1/M2 macrophages (Shaul
et al., 2010; Wentworth et al., 2010), the relative proportion
of M2 macrophages were equally decreased in adipose tissue
of HFD-fed WT and Ad-IKKbKO mice, whereas the proportion ofports 9, 1574–1583, December 11, 2014 ª2014 The Authors 1577
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Figure 3. Adipocyte-Specific IKKb Knockout Mice Resulted in Enhanced Inflammation and Insulin Resistance
(A) Expression of inflammatory cytokines and chemokines in epididymal and subcutaneous adipose tissues of HFD-fed WT and Ad-IKKbKO mice (n = 5–7 per
group). All data are the mean ± SEM, *p < 0.034 compared with NC, **p < 0.0034 compared with WT-HF.
(B and C) H&E staining of epididymal (eAT) and subcutaneous (sAT) adipose tissues in WT and Ad-IKKbKO (KO) mice after HFD feeding for 12 weeks. The arrow
head indicates crown-like structure.
(D and E) Glucose and insulin tolerance test in HFD-fed WT and Ad-IKKbKO mice (n = 7–10 per group). All data are the mean ± SEM, *p < 0.04 compared with
WT-HF, **p < 0.012 compared with WT-HF.
(legend continued on next page)
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M1 and M1/M2 macrophages was further increased in the Ad-
IKKbKOmice (Figure 4C). When we analyzed for the total number
ofeachmacrophagesubsets inwholepadsofepididymal adipose
tissue, all three populations were further increased in both HFD-
fed WT and Ad-IKKbKO mice (Figure S3B). However, when we
determined the number of each subset in the same mass of
epididymal adipose tissue, proinflammatoryM1 andM1/M2mac-
rophages were significantly increased in the Ad-IKKbKO mice,
suggesting that HFD-fed Ad-IKKbKO mice showed increased
accumulation of proinflammatory macrophages (Figure 4D).
In addition to macrophages, other immune cells are also
altered in adipose tissue of HFD-fed mice. Several studies
have demonstrated that CD4+ T cells are decreased while
CD8+ T cells are increased in adipose tissue following HFD
feeding.We therefore examined T cell populations in adipose tis-
sue (Figure S3C). Consistent with previous reports (Feuerer et al.,
2009; Nishimura et al., 2009; Winer et al., 2009), within the CD3+
gated T cell population there was an marked increase in the
proportion of CD8+ T cells and partial decrease in CD4+ T cells
in epididymal adipose tissue of HFD-fed WT mice (Figure 4E).
The increase in CD8+ T cells and decrease in CD4+ T cells
were significantly augmented in HFD-fed Ad-IKKbKO mice (Fig-
ure 4E). Similar results were obtained when the numbers of CD4+
and CD8+ T cells were normalized per adipose tissue mass (Fig-
ure 4F) or by the total number of T cells present (Figure S3D).
In all these cases, the ratios between CD4+/CD8+ T cells were
consistently diminished in the HFD-fed Ad-IKKbKO mice. These
data demonstrate that the loss of adipocyte-specific IKKb
signaling results in an enhanced adipose tissue inflammation in
response to diet-induced obesity.
Adipocyte Differentiation and Cell Survival Is IKKb
Independent
In addition to the regulation of inflammatory gene expression,
NF-kB signaling has been reported to play important roles in
cell survival and cell fate determination (Oeckinghaus et al.,
2011). Thus, it is important to determine whether the Ad-
IKKbKO mice have an alteration in cell autonomous adipocyte
differentiation and/or cell death. As shown in Figures 3C and
S1C, there was no significant difference in adipose tissue cell
mass and adipocytes morphology between WT and Ad-IKKbKO
mice under normal chow feeding conditions. More specifically,
there was no significant difference in the gene expression
of the adipogenesis markers, including Cebpb, Pparg, Fabp2,
and Lep (Figure S4A). In vitro adipocyte differentiation of iso-
lated SVF from WT and Ad-IKKb KO mice also demonstrated
the same time course and extent of differentiation marker
expression (Figure S4B). However, the differentiated adipocytes
from the Ad-IKKb mice displayed reduced cytokine-stimulated
TNF-a, IL-6, and IL-13 expression (Figure S4C) consistent
with a reduction in NF-kB signaling. Moreover, the enhanced
HFD-induced inflammation of Ad-IKKb mice was not a result
of adipocyte cell autonomous apoptosis as there was no(F) Expression of inflammatory mediators in liver of HFD-fedWT and Ad-IKKbKOm
NC, **p < 0.046 compared with WT-HF.
(G) Insulin-stimulated phosphorylation of AKT in liver and epididymal adipose
12–14 weeks and AKT-Thr308 and AKT-Ser473 phosphorylation were determine
Cell Redetectable induction of cleaved (activated) Caspase-3 and
PARP1 (Figure S4D).
Exogenous IL-13 Suppressed HFD-Induced
Inflammation in Adipocyte-Specific IKKb-Deficient Mice
The data presented above demonstrate that HFD induces the
expression of IL-13 in adipocytes through IKKb dependent
signaling. Thus, to determine whether exogenous IL-13 adminis-
tration compensates for IL-13 deficiency in HFD-fed Ad-IKKbKO
mice, HFD-fed WT and Ad-IKKbKO mice were injected every
other day for 2–4 weeks with exogenous IL-13. The body weight
and adipose tissue mass were similar in WT and Ad-IKKbKO
mice after IL-13 administration (Figure 5A). As previously
observed, IL-13 expression in epididymal adipose tissue was
suppressed in Ad-IKKbKO mice. However, IL-13 administration
did not change the expression of IL-13 mRNA in epididymal ad-
ipose tissue (Figure 5B). In contrast, IL-13 administration signif-
icantly reduced the expression of inflammatory cytokines such
as TNF-a, CCL2, and IL-6 in epididymal adipose tissue of
HFD-fed Ad-IKKbKO mice (Figure 5C). Although IL-1b expres-
sion was not significantly suppressed after IL-13 administration,
its expression showed similar trend with other proinflammatory
cytokines. However, IL-13 administration significantly reduced
IL-1b protein secretion as well as TNF-a secretion (Figure S5A).
Although HFD induced macrophage proliferation in epididymal
adipose tissue of Ad-IKKbKO mice (Amano et al., 2014), the
IL-13-mediated suppression of proinflammatory marker levels
occurred without any significant effect on macrophage prolif-
eration (Figures S5B–S5D). Physiologically, the IL-13-mediated
reduction in adipose tissue inflammation directly correlated
with improvement in both glucose tolerance and insulin sensi-
tivity in HFD-fed Ad-IKKbKOmice (Figures 5D and 5E). Together,
these data directly demonstrate that exogenous IL-13 can com-
pensates for the deficiency of IL-13 in HFD-fed Ad-IKKbKO
mice, resulting in the suppression of the HFD-induced adipose
tissue inflammation and partial restoration of glucose tolerance
and insulin sensitivity.
DISCUSSION
IKKb has diverse functions, and suppression of IKKb signaling
prevents inflammatory responses in diverse cells and protects
HFD-induced insulin resistance (Arkan et al., 2005; Cai et al.,
2005; Yuan et al., 2001). In addition, genetic inhibition of IKKb
signaling in specific target tissues such as liver, heart, and brain
also protects against tissue dysfunction as well as insulin resis-
tance (Arkan et al., 2005; Cai et al., 2004, 2005; Maier et al.,
2012). Based on these data, it is generally accepted that IKKb
activation enhances intracellular inflammatory signaling path-
ways. However, the specific role of IKKb in adipocytes has not
been addressed. Here we demonstrate an additional function
for IKKb in adipocytes in the regulation of diet-induced inflamma-
tion and insulin resistance through an IKKb-IL-13 axis (Figure 5F).ice (n = 5–6 per group). All data are themean ± SEM, *p < 0.031 compared with
tissue of HFD-fed WT and Ad-IKKbKO (KO) mice. Mice were fed HFD for
d on the same membrane.
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Figure 4. Proinflammatory Immune Cells Were Accumulated in Adipose Tissue of Adipocyte-Specific IKKb Knockout Mice, Resulting in
Enhanced Inflammation
(A) Proportion of F4/80+CD11c and F4/80+CD11c+ macrophages in epididymal adipose tissues of HFD-fed WT and Ad-IKKbKO mice (n = 6–10 per group).
(B) Proportion of CD206 in F4/80+CD11c and F4/80+CD11c+ macrophages in epididymal adipose tissues of HFD-fed WT and Ad-IKKbKO mice (n = 6–10 per
group).
(legend continued on next page)
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AC D
F
E
B Figure 5. Exogenous IL-13 Administration
Diminished the Inflammation in Adipose Tis-
sue of Adipocyte-Specific IKKb Knockout
Mice
(A and B) Body weight, fat mass, and IL-13
expression in epididymal adipose tissues of HFD-
fedWT and Ad-IKKbKO (KO) mice with exogenous
IL-13 administration (n = 6–8 per group). sAT,
subcutaneous adipose tissue; eAT, epididymal
adipose tissue.
(C) Exogenous IL-13 administration suppressed
inflammatory responses in epididymal adipose
tissues of HFD-fed WT and Ad-IKKbKO (KO) mice
(n = 6–8 per group). All data are the mean ± SEM,
*p < 0.0054 compared withWTwithout IL-13, **p <
0.024 compared with KO without IL-13.
(D and E) Glucose and insulin tolerance test in
HFD-fed Ad-IKKbKO mice with IL-13 administra-
tion (n = 4–6 per group). All data are the mean ±
SEM, *p < 0.021 and **p < 0.05 compared to KO-
HF-IL13.
(F) Schematic model of the pathway responsible
for HFD-induced IL-13 expression in adipocytes
as a feedback pathway to limit the inflammatory
response.HFD-induced proinflammatory cytokine signals such as IL-1b
originating from adipose tissue infiltrating immune cells activate
IKKb in the adipocyte to express and secrete the anti-inflamma-
tory IL-13 cytokine. In turn, IL-13 functions in a paracrine manner
to suppress the expansion of proinflammatory immune cells
within adipose tissue. These data reveal an active defense
mechanism present in adipocytes that limits the extent of tissue
inflammation and insulin resistance through an autoregulatory
loop.
Although adipocytes express IL-13 to induce M2macrophage
differentiation (Kang et al., 2008), normal chow fed lean mice
show little expression of IL-13 in adipocytes (Molofsky et al.,(C and D) Proportion and number of M2 (F4/80+CD11cCD206+), M1 (F4/80+CD11c+CD206), and M1/M2 (F
adipose tissues of HFD-fed WT and Ad-IKKbKO mice (n = 6–10 per group).
(E) Proportion of CD4+ and CD8+ T cells in epididymal adipose tissues of HFD-fed WT and Ad-IKKbKO mice
(F) Cell number of CD4+ and CD8+ T cells in epididymal adipose tissues of HFD-fed WT and Ad-IKKbKO mi
All data are the mean ± SEM, *p < 0.04 compared with NC, **p < 0.04 compared with WT-HF.
Cell Reports 9, 1574–1583, De2013). We also found that IL-13 expres-
sion in adipocytes was dramatically
induced in obese humans and rodents,
suggesting that HFD-induced inflamma-
tory signaling such as IL-1b triggers the
expression of IL-13 in adipocytes. These
data suggest that Th2 CD4+ T cells,
eosinophils, and ILC2 cells produce IL-4
and IL-13 in lean mice to maintain anti-
inflammatory immune response in the
basal state. However, HFD results in
a decreased Th2 CD4+ T cells, eosino-
phils, and ILC2 cells in adipose tissue,
accounting for decreased expression of
the anti-inflammatory cytokine IL-4 andIL-13, whereas adipocyte are now activated to express IL-13
limiting the proinflammatory state.
Constitutively active IKKb has been expressed in adipocytes
using murine adipocyte fatty acid binding protein (aP2) pro-
moter. We expected constitutively active IKKb transgenic mice
showed enhanced systemic and adipose tissue inflammation
(Jiao et al., 2012). However, those transgenic mice displayed in-
sulin sensitivity after HFD feeding due to decreased body weight
gain and increased energy expenditure. In contrast, adipocyte-
specific IKKb deletion using adiponectin-Cre mice interestingly
showed enhanced inflammation and insulin resistance without
any significant differences in body weight gain, food intake,4/80+CD11c+CD206+) macrophages in epididymal
(n = 6–9 per group).
ce (n = 6–9 per group).
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and energy expenditure. These discrepancies may be caused by
decreased body weight gain in transgenic mice after HFD
feeding. Overexpression of constitutively active IKKb may over-
whelm inflammatory responses in adipocytes, resulting in cell
death and lipolysis, and these consequences interfere the inter-
pretation of the role of IKKb in adipocytes. Although aP2 pro-
moter has been used for adipocyte-specific gene expression
and deletion, aP2 promoter activation is not specific for adipo-
cytes (Lee et al., 2013a). In addition, conventional transgenic
mice have potential to insert target genes randomly withmultitar-
get genes, resulting in unexpected results. Thus, results from
adipocyte-specific IKKb deletion using adiponectin-Cre mice
should be more reasonable to interpret the role of IKKb in adipo-
cytes of HFD-fed mice.
These data also beg the question why adipocytes express an
anti-inflammatory adipokine during HFD-induced inflammation
and insulin resistance. Numerous studies have documented
that obesity and HFD create a chronic low-grade inflammation,
but the molecular mechanisms have not been resolved. Not all
obese individuals display inflammation and insulin resistance,
and in fact, approximately 25% of obese individuals are meta-
bolically normal without any evidence for adipose tissue or
systemic inflammation (Primeau et al., 2011). These obese
metabolically normal individuals tend to be substantially
more overweight than insulin-resistant obese individuals with
predominant expansion of subcutaneous adipose tissue. We
therefore hypothesize that the maintenance of low-grade
inflammation may serve to create a state of persistent insulin
resistance to limit the amount of obesity. In this manner, adi-
pose tissue inflammation that induces IKKb-dependent IL-13
expression from adipocytes would serve as a factor to maintain
a chronic low-grade inflammation and thereby limit the magni-
tude of obesity.EXPERIMENTAL PROCEDURES
Animals
C57BL/6Jmicewere obtained from the Jackson Laboratory. Ikbkb floxedmice
(Chen et al., 2003) and adiponectin-cre (Eguchi et al., 2011) mice were gener-
ously obtained from theDr.Michael Karin (University of California) and Dr. Evan
Rosen (Harvard University), respectively. Mice are housed in a facility equip-
ped with a 12 hr light/dark cycle. Animals (8-week-old male mice) were fed
either a NCD (Research Diets) containing 75.9% (kcal) carbohydrates,
14.7% protein, and 9.4% fat or a HFD containing 20% (kcal) carbohydrates,
20% protein, and 60% fat for 12–14 weeks. For IL-13 administration, HFD-
fed mice for 10 weeks were treated with either 1 mg rIL-13 (PeproTech) or an
equal volume of PBS using intraperitoneal injection every other day for 2–
4 weeks. All studies were approved by and performed in compliance with
the guidelines of the Albert Einstein College of Medicine Institutional Animal
Care and Use Committee.
Cell Culture and Treatment
Murine 3T3-L1 adipocyte differentiation were conducted as previously
described (Feng et al., 2011). Fully differentiated 3T3-L1 adipocytes were
placed 2 days in Dulbecco’smodified Eagle’smedium (DMEM) in the presence
of 10% serum and then stimulated with diverse cytokines. For FFA and lipo-
polysaccharide (LPS) treatment, 1 mM palmitate and 2% bovine serum albu-
min (BSA) adducts and 50 ng/ml LPS (Sigma-Aldrich) were used. Fibroblast
culture from SVF and adipocytes differentiation were conducted as described
(Ohno et al., 2012). For Bm-MPs, bone marrow cells were prepared from
femurs and then treated with 10 ng/ml M-CSF (R&D Systems) in high-glucose1582 Cell Reports 9, 1574–1583, December 11, 2014 ª2014 The AutDMEM with 10% serum for 7 days. Bm-MPs were rested in high glucose
DMEM with 10% serum for 24 hr. For positive control of apoptosis, 3T3-L1
cells were treated with 1 mM staurosporine for 4 hr.
Quantitative RT-PCR
QuantitativeRT-PCRwasconductedaspreviouslydescribed (Kwonetal., 2009;
Lee et al., 2013b). Epididymal adipose tissue (mouse), omental adipose tissue
(human), andcellswerehomogenized intoQIAzolLysisReagent (Quiagen).Total
RNA (1 mg) was isolated using RNeasy Mini Kit (QIAGEN Sciences) and reverse
transcribed to cDNAusing theSuperScript VILOcDNA synthesis kit (Invitrogen).
TaqMan (Applied Biosystems) RT-PCR was performed for measurement of
mRNA using standard curves. Gene expression was adjusted by comparison
with Rpl7 expression. Primer-probemixtures for TNF-a and Rpl7 were custom-
ized, and other primer-probe mixtures were from Applied Biosystems.
Statistics
Results are expressed asmean ±SEM. The data were analyzed by a two-tailed
Student’s t test. Differences were considered statistically significant at a level
of p < 0.05.
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